News

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...
Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.
A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.
A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat. Antioxidants and other compounds in coffee (even decaf) can help protect against ...
A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.
Researchers identified a rare variant on a single gene that appears to predispose patients to metabolic ...
Mar. 11, 2025 — Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder ... Novel Therapeutics of Nonalcoholic Fatty Liver Diseases Mar. 6, 2025 — Investigators have ...
Altimmune stock rose on Tuesday without news, possibly due to high short interest. Its new trial for Alcohol Use Disorder and ...